Dr. James A. Merriam Jr., MD

Dr. Merriam practices at Bon Secours St. Francis Downtown in Greenville, South Carolina, part of Bon Secours Mercy Health.

Dr. Merriam's NPI, 1386871093, was assigned on June 20, 2009. Dr. Merriam graduated from University of South Carolina School of Medicine in 2009. Dr. Merriam holds South Carolina license 31767.

Dr. Merriam's primary practice is Bon Secours St. Francis Downtown, at One St Francis Dr, Greenville, SC 29601 in Greenville County. The practice phone is (800) 805-5678. Dr. Merriam also practices at St Francis - Downtown, 1 St Francis Dr, Greenville, SC 29601.

Dr. Merriam's primary practice is Bon Secours St. Francis Downtown in Greenville, South Carolina, part of Bon Secours Mercy Health. Dr. Merriam is also affiliated with Prisma Health Greenville Memorial Hospital. The medical group on file is Bon Secours Medical Group Greenville Specialty Care. Dmand AI also links Dr. Merriam to 1 more hospital, 3 medical groups, 2 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merriam practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Merriam's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Merriam is licensed in South Carolina.

CMS data shows 5,759 Medicare services from Dr. Merriam across 27 procedure codes in 2024, for 1,827 Medicare patients. Medicare paid $280,768 for them.

CMS counts 1,827 Medicare patients who saw Dr. Merriam in 2024. The largest group is 75 to 84, with 758 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Merriam's median patient age at 74, with 49% women.

In 2024, Dr. Merriam wrote 11,293 Medicare Part D claims for 1,363 patients. 78% of them were for generic drugs. CMS names the drug for 10,867 of them, across 96 drugs with 11 or more claims each, at $2,343,767 in total drug cost. In 2023, CMS named 10,500 claims across 94 drugs.

Dr. Merriam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Merriam in 2014. Dr. Merriam's most frequent co-authors are Michael R. Gold, MD and Anil Rajendra, MD.

CMS Open Payments shows 810 general payments to Dr. Merriam from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Amgen Inc. paid the most, $3,064.

Dr. Merriam graduated from University of South Carolina School of Medicine in 2009.